Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma

Hepatology. 2012 Aug;56(2):789-90. doi: 10.1002/hep.25637. Epub 2012 Jul 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Benzenesulfonates / administration & dosage*
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Pyridines / administration & dosage*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Pyridines